Integrichain Blog

Blog

Posts for author: integrichain

Contracts & Pricing Rupal Patel John Whitridge
April 14, 2021

The Current State of Pharmaceutical Price Transparency Reporting

2 Minute Read

What you need to know about navigating a patchwork of state policies, achieving operational readiness, and avoiding compliance risk.

Contracts & Pricing Brendan Crabtree
March 11, 2021

Changes to Medicare Part D, Drug Rebate Program, OIG Final Rule

5 Minute Read

Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.

Contracts & Pricing Brendan Crabtree
February 16, 2021

New ASP Reporting Requirements, 340B Drug Pricing Program and Final Rule,...

4 Minute Read

Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.

Contracts & Pricing Greg Katz Annamarie Lee
October 15, 2020

Public Law Timeline for 2021, OIG Audit Report, Hot Topics at...

2 Minute Read

Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.

Contracts & Pricing Rupal Patel
September 17, 2020

Additional Drug Reporting for NDA and ANDA Holders, FDA NSDE Structured...

2 Minute Read

Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.

Contracts & Pricing Rupal Patel
August 11, 2020

New Drug Pricing Executive Orders, Changes to 340B

2 Minute Read

Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.

Contracts & Pricing John Whitridge
July 22, 2020

New News From California: Pricing Transparency, State Supplemental Program

2 Minute Read

Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.

Contracts & Pricing Rupal Patel
June 19, 2020

The Latest Updates from the Centers for Medicare & Medicaid Services,...

2 Minute Read

Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.

Patient Access Sean McCarthy Edward Doran
June 10, 2020

The Four Challenge Cases in Patient Data Mastering

8 Minute Read

IntegriChain is utilizing AI and machine learning to develop risk score models that will allow Field Reimbursement Managers (FRMs) and similar functions to proactively intervene on behalf of patients...

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper